SAMIDORPHAN

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C21H26N2O4
Molecular Weight	370.4421
Optical Activity	UNSPECIFIED
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

NC(=O)C1=CC=C2C[C@H]3N(CC4CC4)CC[C@@]5(CC(=O)CC[C@@]35O)C2=C1O

InChI

InChIKey=RYIDHLJADOKWFM-MAODMQOUSA-N

InChI=1S/C21H26N2O4/c22-19(26)15-4-3-13-9-16-21(27)6-5-14(24)10-20(21,17(13)18(15)25)7-8-23(16)11-12-1-2-12/h3-4,12,16,25,27H,1-2,5-11H2,(H2,22,26)/t16-,20-,21-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C21H26N2O4
Molecular Weight	370.4421
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	3 / 3
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://clinicaltrials.gov/ct2/show/NCT01903837 | https://www.ncbi.nlm.nih.gov/pubmed/30188587 | https://www.ncbi.nlm.nih.gov/pubmed/30859977

Samidorphan was developed as a sublingually bioavailable µ-opioid receptor antagonist. This drug participated in clinical trials for the treatment of Schizophrenia, Alcohol Dependence, and Binge Eating Disorder. The oral dose pharmacokinetics, safety, and tolerability of samidorphan were evaluated in phase II double blind, placebo-controlled, randomized studies in healthy adults. In addition, the combination of samidorphan (SAM) with buprenorphine (BUP) was studied in phase III clinical trial in patients with major depressive disorder (MDM). It was shown that the long-term treatment did not reveal any new safety findings and confirmed that the risk of abuse and dependence with BUP/SAM was low.

Approval Year

PubMed

Title	Date	PubMed

Patents

Sample Use Guides

In Vivo Use Guide

Samidorphan (Low Dose). Tablets taken once daily

Route of Administration: Oral

Substance Class	Chemical Created by `admin` on `Sat Dec 16 01:45:57 GMT 2023` Edited by `admin` on `Sat Dec 16 01:45:57 GMT 2023`
Record UNII	7W2581Z5L8
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SAMIDORPHAN

Official Name

English

ALKS-5461 COMPONENT SAMIDORPHAN

Code

English

samidorphan [INN]

Common Name

English

Samidorphan [WHO-DD]

Common Name

English

ALKS-33

Code

English

MORPHINAN-3-CARBOXAMIDE, 17-(CYCLOPROPYLMETHYL)-4,14-DIHYDROXY-6-OXO-

Systematic Name

English

SAMIDORPHAN [USAN]

Common Name

English

RDC-0313

Code

English

17-(Cyclopropylmethyl)-4,14-dihydroxy-6-oxomorphinan-3-carboxamide

Systematic Name

English

RDC-0313-00

Code

English

ALKS 33

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C681